Article info
PDFOriginal research
Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B
- Correspondence to Dr Xiaonan Zhang, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China; zhangxiaonan{at}shphc.org.cn; Professor Zhenghong Yuan; zhyuan{at}shmu.edu.cn; Professor Zhanqing Zhang; doctorzzqsphc{at}163.com
Citation
Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B
Publication history
- Received January 15, 2020
- Revised March 10, 2020
- Accepted April 13, 2020
- First published May 13, 2020.
Online issue publication
November 19, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.